GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

ReproCell 4978.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

108

+1.89%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥2.23bn

FY2017FY2026

Net income

−¥591.7m

FY2017FY2026

Free cash flow

−¥481.7m

FY2017FY2026

Shareholders' equity

¥8.85bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥2.23bn¥2.98bn¥2.43bn¥2.95bn¥2.23bn¥1.29bn¥1.20bn¥1.09bn¥926.3m¥1.26bn
Gross profit¥1.01bn¥1.63bn¥1.10bn¥1.13bn¥785.4m¥456.1m¥433.3m¥461.9m¥146.7m¥342.5m
Research and development¥627.2m¥536.8m¥385.0m¥501.5m¥535.3m¥662.0m¥454.8m¥273.2m¥191.6m¥276.4m
Operating income−¥860.1m−¥130.4m−¥409.3m−¥356.2m−¥647.1m−¥1.05bn−¥908.9m−¥781.1m−¥1.03bn−¥944.3m
Net income−¥591.7m¥103.2m−¥31.4m−¥305.3m−¥575.1m−¥812.6m−¥1.02bn−¥601.4m−¥2.17bn−¥911.7m
Diluted earnings per share-6.181.09-0.33-3.59-6.77-10.47-14.23-8.42-30.56-14.26

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥9.65bn¥9.67bn¥9.05bn¥8.36bn¥8.10bn¥6.05bn¥6.55bn¥7.49bn¥6.60bn¥7.85bn
Cash and short-term investments¥6.51bn¥3.94bn¥6.57bn¥6.38bn¥4.64bn¥4.60bn¥5.19bn¥5.71bn¥5.58bn¥5.42bn
Total liabilities¥805.6m¥685.8m¥741.0m¥780.6m¥844.5m¥656.4m¥494.9m¥418.8m¥349.4m¥485.6m
Debt——¥27.2m¥107.8m¥80.0m¥80.0m¥80.0m¥80.0m¥82.5m¥85.7m
Shareholders' equity¥8.85bn¥8.98bn¥8.31bn¥7.58bn¥7.25bn¥5.38bn¥6.05bn¥7.07bn¥6.25bn¥7.37bn
Shares outstanding96m95m94m85m85m78m71m71m71m64m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−¥383.5m¥6.3m−¥11.5m−¥140.5m−¥246.2m−¥648.9m−¥689.8m−¥554.8m−¥636.7m−¥775.0m
Capital spending−¥98.2m−¥86.7m−¥171.4m−¥150.4m−¥43.4m−¥59.9m−¥120.1m−¥91.9m−¥43.4m−¥65.5m
Free cash flow−¥481.7m−¥80.4m−¥182.9m−¥290.9m−¥289.6m−¥708.7m−¥809.9m−¥646.8m−¥680.1m−¥840.6m
Dividends paid————−¥80.0m—————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥546.7m¥623.7m¥635.7m¥498.2m¥475.8m¥909.8m¥748.4m¥700.6m
Gross profit¥244.4m¥300.9m¥326.1m¥191.8m¥193.8m¥528.9m¥412.2m¥377.9m
Operating income−¥310.9m−¥183.8m−¥129.6m−¥255.6m−¥291.1m¥49.8m−¥31.1m−¥33.4m
Net income−¥149.5m−¥132.8m¥27.4m−¥182.0m−¥304.3m¥134.3m¥73.2m−¥29.0m
Diluted earnings per share-1.56-1.390.29-1.92-3.211.420.78-0.31
Total assets¥9.80bn¥9.65bn¥10.41bn¥9.36bn¥9.25bn¥9.67bn¥11.23bn¥9.42bn
Cash and short-term investments¥5.62bn¥6.51bn¥6.85bn¥5.75bn¥4.72bn¥3.94bn¥4.43bn¥5.17bn
Shareholders' equity¥9.07bn¥8.85bn¥8.79bn¥8.68bn¥8.66bn¥8.98bn¥8.89bn¥8.74bn

Financial ratios

Data as of 30 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Gross margin45.3%54.7%45.5%38.2%35.1%35.5%———
Operating margin-38.5%-4.4%-16.9%-12.1%-29.0%-81.5%———
Net margin-26.5%3.5%-1.3%-10.3%-25.7%-63.2%———
Return on equity-6.7%1.1%-0.4%-4.0%-7.9%-15.1%———
Return on assets-6.1%1.1%-0.3%-3.7%-7.1%-13.4%———
Free cash flow yield-2.1%0.7%1.2%0.1%-1.7%-5.3%———
Revenue growth-25.0%22.7%-17.8%32.2%73.7%7.2%———
Earnings growth-673.1%-428.6%-89.7%-46.9%-29.2%-20.1%———
Current ratio11.87x7.64x10.91x9.58x6.50x9.48x———
Debt to equity——0.00x0.01x0.01x0.03x0.01x0.01x—
Equity ratio91.7%92.9%91.8%90.7%89.6%89.0%———
Interest coverage———-4452.80x-1892.18x-3285.41x-2705.17x-1212.92x-1033.01x
R&D as a share of sales28.1%18.0%15.9%17.0%24.0%51.5%———
Buybacks as a share of market value-1.0%-0.5%-10.8%-0.2%-9.4%-8.7%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-8.9%11.7%7.7%
Operating income34.2%-3.9%-1.7%
Net income24.7%-6.1%-11.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin50.7%46.0%43.3%39.4%
Operating margin-19.0%-16.6%-24.5%-41.4%
Net margin-9.4%-7.8%-15.7%-45.2%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-18.8128.4-311.9-48.8-44.7-22.6-28.9-25.1-6.3-22.3
Price to sales5.04.54.05.011.514.224.513.814.716.2

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 5-for-1 split · 28 Aug 2013

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.